Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. - Wikidata - wikimedia - TriplyDB

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.

http://www.wikidata.org/entity/Q37418736

about

Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.Hendra virus and Nipah virus animal vaccines.Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine.Rhabdovirus-based vaccine platforms against henipaviruses Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.RNA-based viral vectors.Henipavirus Encephalitis: Recent Developments and Advances.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Protection from Hendra virus infection with Canarypox recombinant vaccine.A VLP-based vaccine provides complete protection against Nipah virus challenge following multiple-dose or single-dose vaccination schedules in a hamster model.Favipiravir (T-705) protects against Nipah virus infection in the hamster model.Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA.

P2860

Q28223031-31A59AF1-C191-459A-9F32-A7063B950214 Q30370147-55FC5A41-6D1D-4C17-98AD-06B7E96BD999 Q30387821-353FDF56-C384-46B6-AAE9-F16E239A8EC4 Q33894405-6F902FFF-F883-4133-83F4-ED7EF387A565 Q34992537-AFF4590F-4A29-473E-900B-4640EDB25EFE Q36791009-51E18396-E251-4199-963F-2D487868B504 Q37427047-25565986-C6F1-43E7-83A2-4D0957FD0643 Q38266413-9D39D819-095A-4837-B127-22C26B0BAEB8 Q38567114-83719BFD-B438-4111-8927-8A00CB8CAEF0 Q40052567-36FAFBBE-565E-4FA8-8D37-E4F439EBBC00 Q47105971-013E8AFA-2BEA-461D-9B58-2B0854BF3535 Q47140392-A045BB59-BDF3-470F-87D4-4C46DF46F207 Q54989893-6B4E5825-6E1B-455C-A650-8D374092CF10 Q55400316-0992A91C-34A0-419D-9783-85258D03963A

P2860

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.

http://www.wikidata.org/entity/Q37418736

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Single-dose replication-defect ...... challenge in Syrian hamsters.

@en

Single-dose replication-defect ...... challenge in Syrian hamsters.

@nl

type

label

Single-dose replication-defect ...... challenge in Syrian hamsters.

@en

Single-dose replication-defect ...... challenge in Syrian hamsters.

@nl

altLabel

Single-dose replication-defect ...... l challenge in Syrian hamsters

@en

prefLabel

Single-dose replication-defect ...... challenge in Syrian hamsters.

@en

Single-dose replication-defect ...... challenge in Syrian hamsters.

@nl

P1433

Q37418736-9D867C4A-CC14-44A6-8BF7-F873D4D47938

P1476

Q37418736-58E5E6A4-C352-4FBC-9F33-EF5F556E4BF7

P2093

Q37418736-2E0B5A26-73FE-40BD-8390-388D7748CDE9

Q37418736-47561B61-DA2A-4DD7-B845-6A1E269C0CB4

Q37418736-720D59D8-24FD-4F2A-AE44-F25D71623C15

Q37418736-76453AF0-DE6A-4CC8-A0ED-4B067B19B145

Q37418736-BDC686F0-8767-4D6E-8409-D6EB1092E3E1

Q37418736-EDD0A264-912A-43C9-939C-7621CF8C4C69

Q37418736-FCBD354F-6D38-429B-880C-3AC316446CB3

P2860

Q37418736-093099EC-32EF-4BD9-ADCC-5445CB41F4E6

Q37418736-2047BB63-AEF6-43A8-9BA3-A9E5D4C792CC

Q37418736-25154FA8-BA75-4B87-983D-948980D442A4

Q37418736-2EF11888-25CA-4DC4-981F-99A90B0B3E95

Q37418736-30233ADA-03D9-4F42-805B-67953131B372

Q37418736-30E82C2A-75EC-4950-A81F-B8344B213F15

Q37418736-31F62857-1731-4847-A439-AA318B7E7B5C

Q37418736-3EC45127-F241-4B60-AFB2-EA2F669B291E

Q37418736-4D3A6D99-715D-407E-AAF6-65AB2AB7C22C

Q37418736-50DB98E1-91B6-46E1-8234-8976F9E71BD9

P304

Q37418736-56765FBE-CF6B-4F1B-82D6-328389C11C2C

P31

Q37418736-8D62DBBB-F0B7-41FF-9D0A-D1791EE30D6E

P356

Q37418736-9EF19778-A08D-4C69-8A23-0150F3A43D99

P407

Q37418736-9DF8DD1B-74C5-4DD1-BC0E-FF06D7A200C5

P478

Q37418736-0255CE6E-060E-4899-B87E-71E212F8EEC4

P50

Q37418736-092EFA4D-A0EB-41B8-A24A-7061BB735E94

Q37418736-1EFC1F3C-2BE1-4C2C-AB0F-4DD5B4A40FAF

P577

Q37418736-792760B0-5B68-4998-8498-798CF46A0AC1

P5875

Q37418736-C0A08F8D-2B6B-45D0-8478-918C5DE7583C

P698

Q37418736-91B02669-7EEA-4894-BF62-A143B46262BA

P921

Q37418736-AB1094D6-657A-4ECA-8EB3-4B2552379F16

P932

Q37418736-3E7CBEFB-B1D6-41EF-9451-EEAC412BF0EB

P356

J.ANTIVIRAL.2013.10.012

P1433

Antiviral Research

P1476

Single-dose replication-defect ...... challenge in Syrian hamsters.

@en

P2093

Anasuya Chattopadhyay

http://www.w3.org/2001/XMLSchema#string

Brian H Bird

http://www.w3.org/2001/XMLSchema#string

Brock E Martin

http://www.w3.org/2001/XMLSchema#string

Christina F Spiropoulou

http://www.w3.org/2001/XMLSchema#string

Clifton P Drew

http://www.w3.org/2001/XMLSchema#string

Joann D Coleman

http://www.w3.org/2001/XMLSchema#string

John K Rose

http://www.w3.org/2001/XMLSchema#string

P2860

A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge

Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster

Nipah virus: a recently emergent deadly paramyxovirus.

Molecular characterization of Nipah virus, a newly emergent paramyxovirus.

Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression.

Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge

Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.

A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.

P304

26-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ANTIVIRAL.2013.10.012

http://www.w3.org/2001/XMLSchema#string

P407

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Stuart T Nichol

P577

2013-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258252233

http://www.w3.org/2001/XMLSchema#string

P698

24184127

http://www.w3.org/2001/XMLSchema#string

P921

P932

3874889

http://www.w3.org/2001/XMLSchema#string